Type of Study:
Type 1 diabetes patients who are between 1 to 17 years
1-17 years, Male and Female
Participants will receive at no cost: study product, study materials and study-specific procedures.
The reason for this study is to compare a ultra-rapid lispro to insulin lispro (Humalog) in children and adolescents with type 1 diabetes (T1D).